These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 3568416

  • 1. The effect of 2,4-dihydroxypyridine-N-oxide, a new orally active iron chelator, on iron excretion in mice.
    Kontoghiorghes GJ.
    Clin Chim Acta; 1987 Mar 16; 163(2):137-41. PubMed ID: 3568416
    [Abstract] [Full Text] [Related]

  • 2. 2-Hydroxypyridine-N-oxides: effective new chelators in iron mobilisation.
    Kontoghiorghes GJ.
    Biochim Biophys Acta; 1987 Apr 16; 924(1):13-8. PubMed ID: 3828392
    [Abstract] [Full Text] [Related]

  • 3. Orally active alpha-ketohydroxy pyridine iron chelators intended for clinical use: in vivo studies in rabbits.
    Kontoghiorghes GJ, Hoffbrand AV.
    Br J Haematol; 1986 Apr 16; 62(4):607-13. PubMed ID: 3964556
    [Abstract] [Full Text] [Related]

  • 4. Selection of a new generation of orally active alpha-ketohydroxypyridine iron chelators intended for use in the treatment of iron overload.
    Kontoghiorghes GJ, Barr J, Nortey P, Sheppard L.
    Am J Hematol; 1993 Apr 16; 42(4):340-9. PubMed ID: 8493983
    [Abstract] [Full Text] [Related]

  • 5. Orally active alpha-ketohydroxypyridine iron chelators: studies in mice.
    Kontoghiorghes GJ.
    Mol Pharmacol; 1986 Dec 16; 30(6):670-3. PubMed ID: 3785144
    [Abstract] [Full Text] [Related]

  • 6. Dose response studies using desferrioxamine and orally active chelators in a mouse model.
    Kontoghiorghes GJ.
    Scand J Haematol; 1986 Jul 16; 37(1):63-70. PubMed ID: 3764334
    [Abstract] [Full Text] [Related]

  • 7. Biliary iron excretion in rats following pyridoxal isonicotinoyl hydrazone.
    Cikrt M, Ponka P, Necas E, Neuwirt J.
    Br J Haematol; 1980 Jun 16; 45(2):275-83. PubMed ID: 7437326
    [Abstract] [Full Text] [Related]

  • 8. Iron mobilisation from lactoferrin by chelators at physiological pH.
    Kontoghiorghes GJ.
    Biochim Biophys Acta; 1986 Jun 19; 882(2):267-70. PubMed ID: 3708002
    [Abstract] [Full Text] [Related]

  • 9. Orally active alpha-ketohydroxypyridine iron chelators: effects on iron and other metal mobilisations.
    Kontoghiorghes GJ.
    Acta Haematol; 1987 Jun 19; 78(2-3):212-6. PubMed ID: 3120474
    [Abstract] [Full Text] [Related]

  • 10. In vivo evaluation of hydroxypyridone iron chelators in a mouse model.
    Gyparaki M, Porter JB, Hirani S, Streater M, Hider RC, Huehns ER.
    Acta Haematol; 1987 Jun 19; 78(2-3):217-21. PubMed ID: 3120475
    [Abstract] [Full Text] [Related]

  • 11. Comparative study of iron mobilization from haemosiderin, ferritin and iron(III) precipitates by chelators.
    Kontoghiorghes GJ, Chambers S, Hoffbrand AV.
    Biochem J; 1987 Jan 01; 241(1):87-92. PubMed ID: 3566714
    [Abstract] [Full Text] [Related]

  • 12. Chelators affecting iron absorption in mice.
    Kontoghiorghes GJ.
    Arzneimittelforschung; 1990 Dec 01; 40(12):1332-5. PubMed ID: 2095129
    [Abstract] [Full Text] [Related]

  • 13. New orally effective iron chelators. Animal studies.
    Hershko C, Link G, Pinson A, Avramovici-Grisaru S, Sarel S, Peter HH, Hider RC, Grady RW.
    Ann N Y Acad Sci; 1990 Dec 01; 612():351-60. PubMed ID: 2291563
    [No Abstract] [Full Text] [Related]

  • 14. Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.
    Kontoghiorghes GJ, Aldouri MA, Hoffbrand AV, Barr J, Wonke B, Kourouclaris T, Sheppard L.
    Br Med J (Clin Res Ed); 1987 Dec 12; 295(6612):1509-12. PubMed ID: 3122880
    [Abstract] [Full Text] [Related]

  • 15. Iron chelation studies using desferrioxamine and the potential oral chelator, 1,2-dimethyl-3-hydroxypyrid-4-one, in normal and iron loaded rats.
    Kontoghiorghes GJ, Sheppard L, Hoffbrand AV, Charalambous J, Tikerpae J, Pippard MJ.
    J Clin Pathol; 1987 Apr 12; 40(4):404-8. PubMed ID: 3584483
    [Abstract] [Full Text] [Related]

  • 16. The study of iron mobilisation from transferrin using alpha-ketohydroxy heteroaromatic chelators.
    Kontoghiorghes GJ.
    Biochim Biophys Acta; 1986 Jan 30; 869(2):141-6. PubMed ID: 3942757
    [Abstract] [Full Text] [Related]

  • 17. New orally active alpha-ketohydroxy pyridine chelators for the treatment of iron overload.
    Kontoghiorghes GJ.
    Birth Defects Orig Artic Ser; 1988 Jan 30; 23(5B):97-103. PubMed ID: 3390580
    [No Abstract] [Full Text] [Related]

  • 18. Liposome entrapped desferrioxamine and iron transporting ionophores: a new approach to iron chelation therapy.
    Young SP, Baker E, Huehns ER.
    Br J Haematol; 1979 Mar 30; 41(3):357-63. PubMed ID: 427040
    [Abstract] [Full Text] [Related]

  • 19. PCTH: a novel orally active chelator of the aroylhydrazone class that induces iron excretion from mice.
    Wong CS, Kwok JC, Richardson DR.
    Biochim Biophys Acta; 2004 Dec 24; 1739(1):70-80. PubMed ID: 15607119
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.